Pieper Steven

CIK 00018757142 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001875714

Recent Transactions

39 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Appreciation Right
2025-01-31+300,000→ 300,000 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−110,750→ 1,299,011 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−66,450→ 1,232,561 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31+185,000→ 1,417,561 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-03$3.61/sh−32,059→ 1,409,761 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-11-22$1.55/sh+19,483→ 1,441,820 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2024-11-22−16,843→ 0 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2024-11-22−2,640→ 0 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-07-28$2.61/sh−14,767→ 1,422,337 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31$2.46/sh−110,750→ 1,437,104 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31+450,000→ 1,626,912 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-29$2.66/sh−4,379→ 1,547,854 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-03$2.24/sh−23,067→ 1,552,233 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-11-20$1.95/sh+28,000→ 1,176,912 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-07-28$2.53/sh−10,200→ 1,575,300 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31$1.24/sh−778→ 1,585,500 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31+750,000→ 1,148,912 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-29$1.26/sh−3,590→ 1,586,278 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-03$1.12/sh−23,067→ 1,589,868 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-07-28$1.43/sh−9,767→ 1,612,935 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-31$2.11/sh−750→ 1,622,702 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-29$2.11/sh−3,460→ 1,623,452 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-03+200,000→ 388,834 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-11-10$2.00/sh+25,000→ 183,108 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−14,036→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−27,891→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+14,036→ 14,036 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+27,891→ 27,891 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+23,775→ 23,775 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+12,500→ 12,500 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+134,333→ 158,108 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+16,843→ 16,843 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+2,640→ 2,640 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−23,775→ 134,333 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−16,843→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−12,500→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−134,333→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−2,640→ 0 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2021-07-28+100,000→ 158,858 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov